Causes and countermeasures for repeated outbreaks of hepatitis A among adults in Korea.


Journal

Epidemiology and health
ISSN: 2092-7193
Titre abrégé: Epidemiol Health
Pays: Korea (South)
ID NLM: 101519472

Informations de publication

Date de publication:
2019
Historique:
received: 21 08 2019
accepted: 22 09 2019
entrez: 13 11 2019
pubmed: 13 11 2019
medline: 26 11 2019
Statut: ppublish

Résumé

The 2019 hepatitis A outbreak has become increasingly prevalent among adults in Korea and is the largest outbreak since that in 2009-2010. The incidence in the current outbreak is highest among adults aged 35-44 years, corresponding to the peak incidence among those aged 25-34 years 10 years ago. This may indicate a cohort effect in the corresponding age group. Causes of these repeated outbreaks of hepatitis A in Korea are low level of immunity among adults, Korean food culture that consumes raw seafood such as salted clam and inadequate public health system. Among countermeasures, along with general infectious disease control measures including control of the infectious agent, infection spread, and host, urgent actions are needed to review the vaccination policy and establish an adequate public health system.

Identifiants

pubmed: 31715685
pii: epih.e2019038
doi: 10.4178/epih.e2019038
pmc: PMC6883026
doi:

Substances chimiques

Hepatitis A Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2019038

Références

J Infect Dis. 1991 Nov;164(5):852-9
pubmed: 1658157
Epidemiol Health. 2014 Aug 18;36:e2014011
pubmed: 25139060
Infect Chemother. 2019 Mar;51(1):62-66
pubmed: 30941940
Hepatology. 2006 Feb;43(2 Suppl 1):S164-72
pubmed: 16447259
BMC Infect Dis. 2012 Oct 25;12:271
pubmed: 23098290
Clin Mol Hepatol. 2017 Sep;23(3):196-204
pubmed: 28942621
Vaccine. 2016 Jul 29;34(35):4243-4249
pubmed: 27317459
PLoS One. 2017 Oct 24;12(10):e0186257
pubmed: 29065115
J Korean Med Sci. 2015 Apr;30(4):353-9
pubmed: 25829800
PLoS One. 2017 Jan 18;12(1):e0170432
pubmed: 28099530
PLoS One. 2017 Dec 8;12(12):e0189210
pubmed: 29220416
Vaccine. 2013 Jan 2;31(2):285-6
pubmed: 23142134
J Clin Virol. 2017 Sep;94:63-66
pubmed: 28759774
J Korean Med Sci. 2013 Jun;28(6):908-14
pubmed: 23772157
Epidemiol Health. 2016 Sep 30;38:e2016040
pubmed: 27703127

Auteurs

Moran Ki (M)

Department of Cancer Control and Population Health, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea.

Hyunjin Son (H)

Busan Center for Infectious Disease Control and Prevention, Pusan National University Hospital, Busan, Korea.

Bo Youl Choi (BY)

Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH